Related Experiment Video
Updated: Feb 7, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
STAT3 as a therapeutic target in head and neck cancer
Rebecca J Leeman1, Vivian Wai Yan Lui, Jennifer Rubin Grandis
1Department of Otolaryngology, The Eye and Ear Institute, Pittsburgh, PA 15213, USA.
Abstract:
The signal transducer and activator of transcription (STAT) proteins relay signals from cytokine receptors and receptor tyrosine kinases on the cell surface to the nucleus, where they affect the transcription of genes involved in normal cell functions, including growth, apoptosis and differentiation. STAT3 has been found to be constitutively active in head and neck squamous cell carcinoma (HNSCC) as well as in other epithelial malignancies. In HNSCC, STAT3 alters the cell cycle, prevents apoptosis, and mediates the proliferation and survival of tumour cells. Several therapeutic approaches are being developed to target STAT3, including molecules that block either dimerisation or DNA binding by STAT3, strategies to decrease STAT3 expression and drugs that inhibit STAT3 function. Strategies that block STAT3 may prove efficacious for cancer treatment.
Insights
Signal transducer and activator of transcription 3 (STAT3) is constitutively active in head and neck squamous cell carcinoma, promoting tumor cell proliferation and survival. Targeting STAT3 offers a promising therapeutic strategy for HNSCC treatment.
Area of Science:
- Molecular Biology
- Oncology
- Cell Signaling
Background:
- Signal transducer and activator of transcription (STAT) proteins are key mediators of intracellular signaling pathways.
- STAT3 is frequently constitutively active in various epithelial malignancies, including head and neck squamous cell carcinoma (HNSCC).
Purpose of the Study:
- To review the role of STAT3 in HNSCC pathogenesis.
- To discuss emerging therapeutic strategies targeting STAT3 for HNSCC treatment.
Main Methods:
- Literature review of studies investigating STAT3 in HNSCC.
- Analysis of current and developing therapeutic approaches targeting STAT3.
Main Results:
- Constitutive STAT3 activation in HNSCC drives tumor cell proliferation, survival, and resistance to apoptosis.
- Multiple therapeutic strategies, including inhibition of dimerization, DNA binding, expression, or function, are under development.
Conclusions:
- STAT3 plays a critical role in HNSCC development and progression.
- Targeting STAT3 represents a potentially effective therapeutic approach for HNSCC.
Related Concept Videos
Arteries of the Head and Neck
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
Veins of Head and Neck
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Muscles of the Anterior Neck
Muscles that Move the Head
The bilateral sternocleidomastoid, or SCM, and the suprahyoid and infrahyoid muscles are significant head flexors. The SCM muscles originate at the sternum and clavicle and attach to the mastoid process of the temporal bone. The SCM contracts bilaterally to bend the head forward, whereas...
Therapeutic Index

